VTI Visioneering Technologies

Visioneering Technologies, Inc. Expands US Sales Force

Visioneering Technologies, Inc. (ASX: VTI), a US-based medical device company (‘Visioneering’ or ‘The Company’) engaged in the design, manufacture, sale and distribution of its proprietary NaturalVue® Multifocal 1 Day Contact Lenses, is pleased to announce the recent expansion of its US sales force.

In line with Visioneering’s plan to broaden and accelerate its US launch of NaturalVue Multifocal Contact Lenses, they have appointed Mr. Joshua Suarez as new District Sales Manager for the western United States and added 10 new sales representatives across the country.

Mr. Suarez has over 14 years’ experience in senior sales roles in the healthcare and medtech industries in the US. Most recently, Joshua was the Regional Business Manager at Voyce (i4C Innovations Inc.) where he built a new region and led sales and training for the start-up remote monitoring device company. Prior to this, he was the Senior Area Business Manager at Zoetis Inc.

Visioneering’s Senior Vice President of Sales & Marketing, Tony Sommer stated he was delighted with the seniority and depth of experience their new hires bring to VTI. “I am confident that Joshua’s leadership skills and extensive experience will enrich VTI as we focus on building strong and long term partnerships with the eye-care industry.”

Mr. Sommer continued “There is significant interest building around the NaturalVue Multifocal. Our recent successful finance raise is enabling us to increase our sales coverage and strengthen our commercialization efforts across the country.”

These new, highly-experienced sales representatives will cover Northern and Southern California (Los Angeles, San Diego, Sacramento and San Francisco), the northeast (including New York City, Long Island, upstate New York, Connecticut and New Jersey), Ohio (Cincinnati) and the Carolinas.

CEO and Executive Director Dr. Stephen Snowdy said, “We plan to build out our US sales force to 45 sales representatives over the next 12 months, and we are off to a running start with the addition of 11 new sales personnel.”

About Visioneering Technologies, Inc.

Visioneering Technologies, Inc. (VTI), headquartered in northern Atlanta, Georgia, is an innovative company dedicated to developing products that improve vision. With a portfolio of technologies, the company uses creative and differentiated design approaches to develop products that enhance practitioner and patient experiences. VTI optical designs have been awarded nine patents worldwide, with an additional ten pending. Strength in science, an entrepreneurial culture, and the ability to bring technology to life make Visioneering Technologies, Inc. a company to watch. For more information, visit www.vtivision.com/ or call 844-884-5367, ext. 104.

EN
05/05/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Visioneering Technologies

Visioneering Technologies Inc: 1 director

A director at Visioneering Technologies Inc maiden bought 124,872 shares at 0.400AUD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the...

 PRESS RELEASE

Visioneering Technologies obtient la marque CE pour sa gamme de lentil...

ATLANTA--(BUSINESS WIRE)-- Visioneering Technologies, Inc. (ASX : VTI), une société innovante basée aux États-Unis spécialisée dans le développement de produits avancés visant à améliorer la vision, a annoncé aujourd'hui avoir reçu la marque CE européenne (Conformité Européenne) pour la commercialisation dans l'Union européenne de son portefeuille de lentilles de contact journalières exclusives de marque NaturalVue® (etafilcon A), y compris les lentilles Sphere, Toric, Multifocal et Multifocal Toric. La marque CE obtenue par VTI inclu...

 PRESS RELEASE

Visioneering Technologies Achieves CE Mark for NaturalVue® Family of ...

ATLANTA--(BUSINESS WIRE)-- Visioneering Technologies, Inc. (ASX: VTI), an innovative US-based medical device company dedicated to developing advanced products that improve vision, announced today receipt of the European CE Mark (Conformité Européenne) for commercialization in the European Union of its portfolio of proprietary NaturalVue® (etafilcon A) brand 1 Day Contact Lenses, including Sphere, Toric, Multifocal and Multifocal Toric. VTI’s CE Mark includes an indication for VTI’s unique NaturalVue Multifocal (NVMF) for myopic progre...

 PRESS RELEASE

Newly Expanded Evidence from Clinical Practice on NaturalVue® (etafil...

ATLANTA--(BUSINESS WIRE)-- Visioneering Technologies, Inc (ASX: VTI), a US-based medical device company (‘Visioneering’ or ‘The Company’) engaged in the design, manufacture, sale and distribution of its proprietary NaturalVue® Multifocal 1 Day (NaturalVue MF) Contact Lenses has today announced data presented at the Global Specialty Lens Symposium (GSLS). The new data highlights the impact of NaturalVue Multifocal on paediatric myopia. Myopia (also known as nearsightedness) is a condition with a rapidly increasing prevalence tha...

 PRESS RELEASE

Visioneering Technologies, Inc. Expands US Sales Force

ATLANTA--(BUSINESS WIRE)-- Visioneering Technologies, Inc. (ASX: VTI), a US-based medical device company (‘Visioneering’ or ‘The Company’) engaged in the design, manufacture, sale and distribution of its proprietary NaturalVue® Multifocal 1 Day Contact Lenses, is pleased to announce the recent expansion of its US sales force. In line with Visioneering’s plan to broaden and accelerate its US launch of NaturalVue Multifocal Contact Lenses, they have appointed Mr. Joshua Suarez as new District Sales Manager for the western Unite...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch